跳至主要内容
临床试验/TCTR20220427002
TCTR20220427002尚未招募1 期

Efficacy and safety of wrist ankle acupuncture combined with oxycodone hydrochloride in the treatment of hepatocellular carcinoma with moderate and severe cancer pain: A protocol of a randomized, single-blind, placebo-controlled clinical trial

Zhilin Zhou0 个研究点目标入组 45 人开始时间: 2022年4月27日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 1 .Patients who are in accordance with the diagnosis of HCC .
  • 2. Aged: 18 to 75 years old, stable and conscious.
  • 3. Patients who have moderate and severe pain, and the 11-point numerical rating scale
  • 4. Patients whose expected survival is over 6 months.
  • (5). Patients who have strong compliance and have signed informed consent.

排除标准

  • 1. Patients who are accompanied by infectious diseases, diseases of blood system
  • 2. Patients who have history of acupuncture syncope
  • 3. Women in pregnancy or lactation
  • 4. Patients who have pain associated with causes other than HCC
  • 5. Complicated with other acute symptoms.
  • 6. Skin ulceration at the needling site.

研究者

发起方
Zhilin Zhou

相似试验